Railway Pension Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Railway Pension Investments's REGN Position: Q4 2024 in Review
Railway Pension Investments sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 15,000 shares — an estimated $15.8M sold.
Railway Pension Investments first reported a position in REGN in Q1 2020 and held it in 16 quarters. The position peaked at $113M in Q1 2023. 1,321 funds tracked by Wall St. Rank hold REGN as of Q4 2024.
- Railway Pension Investments reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- Railway Pension Investments sold 15,000 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $15.8M.
- Railway Pension Investments first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 16 quarters.
- Railway Pension Investments's Regeneron Pharmaceuticals position peaked at $113M in Q1 2023.
- 1,321 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.
Based on Railway Pension Investments's 13F filing for Q4 2024, filed 12 Feb 2025.